Oracle Health Sciences InForm Advanced Molecular Analytics Enables Life Sciences Organizations to Incorporate Genomic Data into Clinical R&D for Targeted, Biomarker-Driven Clinical TrialsSolution Extends the Capabilities of Oracle Health Sciences InForm GTM to Effectively Collect, Store and Analyze Genomic Data
ORACLE INDUSTRY CONNECT, BOSTON – March 25, 2014
News SummaryBiomarkers are becoming a key component of clinical trial design, enabling researchers to rapidly find subjects with similar clinical and omics characteristics. Oracle Health Sciences InForm Advanced Molecular Analytics is one of the first commercially available cloud-delivery solutions to incorporate genomics into the clinical data capture and management process. Integrated with Oracle Health Sciences InForm GTM, the solution enables clinical researchers to effectively capture, aggregate and analyze molecular data along with clinical data to provide the information needed to identify new predictive biomarkers. The solution facilitates the stratification of patients into target populations of responders to accelerate trials and improve drug and therapeutic outcomes.
News Facts Oracle Health Sciences today announced Oracle Health Sciences InForm Advanced Molecular Analytics. Integrated with Oracle Health Sciences InForm GTM, the solution enables clinical trial managers to systematically and effectively collect, store and analyze genomic data captured in a clinical trial.
The new capabilities of Oracle Health Sciences InForm Advanced Molecular Analytics help life sciences organizations to stratify patients and reduce research and development costs by leveraging targeted drug development approaches and decreasing study size and length. The solution also helps researchers identify new indications and therapies through post-trial, cross-study analysis with molecular data.
Collecting biomarker data is typically a difficult manual effort, aggregating data scattered across spreadsheets, file systems and siloed transaction systems. With Oracle Health Sciences InForm Advanced Molecular Analytics, researchers have consolidated access to both clinical and genomic data for numerous purposes, such as submission or the design of more exploratory translational research studies, including those that can generate petabytes of data from thousands of whole genome sequences.
Life sciences organizations can gain a single, integrated view of genomic, genetic and clinical data, enabling clinical researchers to identify and validate new targets. The solution supports multiple omics modalities and targeted gene panels and can scale to handle hundreds of thousands of whole genomes.
Clinical researchers can study patient genomic profiles, analyze differences and compare molecular data against common large public domain data sets, such as The Cancer Genome Atlas
© Издание 12NEWS (ИП Маринин А.Л.) 12news.ru, 2014
Корпорация Oracle в СНГ предоставляет полный набор услуг по продаже программного обеспечения Oracle, технической поддержке, обучению, консалтингу, внедрению комплекса Oracle E-Business Suite. В Москве, Киеве и Алмате работает более 170 сотрудников Oracle.
